Medacta USA Opens New Headquarters in Chicago: 5 Key Takeaways

Spinal Tech

Medacta USA has opened its new headquarters in Chicago.

Here are five key takeaways:


1. The 20,000-square-foot facility is expected to bring more than 50 jobs to the city. Medacta USA relocated its headquarters from Southern California to better support the company's expansion into the United States orthopedics market. Medacta USA is a subsidiary of Medacta International, a privately held company focused on developing joint replacement and spine surgery products.


"I am pleased to welcome Medacta International's new U.S. headquarters to Chicago," said Chicago Mayor Rahm Emanuel in a news release. "One of the main objectives of the Plan for Economic Growth and Jobs is to ensure that companies like Medacta see Chicago as the ideal location for new corporate headquarters. This is proof that our efforts to create new jobs and grow the city's economy are working."


2. Medacta International is headquartered in Castel San Pietro, Switzerland, and it operates in 26 countries. Medacta USA was established in 2009. "Since entering the market in 2009, Medacta USA has experienced rapid year-over-year growth, and its products have received accolades from surgeons and patients nationwide," said Medacta USA President Eric Dremel in a news release.


3. Eric Dremel was recently appointed president of the company. He has more than 27 years of experience in the development and commercialization of orthopedic products, and most recently served as general manager of Medacta USA's Joint Reconstruction Division.


4. The official opening of the new headquarters coincides with the first Advanced Anterior Minimally Invasive Surgery Hip Course at Northwestern University in Chicago and the 161st Basic AMIS Learning Center, a professional course. Pioneered by Medacta and leading orthopedic surgeons, AMIS is a muscle-sparing technique for hip replacement.


5. Medacta is a major player in the orthopedic products market, which is expected to see huge growth in the next few years, According to an ORTHOWORLD report, worldwide orthopedic product sales are expected to exceed $54 billion by 2018.


The global spine surgery devices market will also see substantial growth. It is forecasted to be worth $14.8 billion by 2017, according to a MarketsandMarkets report. The market was valued at $11.5 billion in 2012 and estimated annual growth rate is 5.1 percent over the next five years.

More Articles on Devices:

5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers